KORU Medical Systems Inc
KRMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$156.17M
Close$
$-4.01
220.6% downside
Current Fair Value
220.6% downsideOvervalued by 220.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $156.17 Million |
|---|---|
| Enterprise Value | $151.12 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.06 |
| Beta | 0.41 |
| Outstanding Shares | 46,083,893 |
Return
| Return on Equity | -10.08% |
|---|---|
| Return on Assets | -6.51% |
| Return on Invested Capital | -7.27% |
Valuation & Multiples
| P/E Ratio | -86.73 |
|---|---|
| PEG | 39.06 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.35 |
| Enterprise Value to EBIT | -100 |
| Enterprise Value to Net Income | -84 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$11.62 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$11.38 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 32,600▲ 48.18% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 45.13%▼ 0.12% |
|---|---|
| Total Invested | $90.04M▼ 25.84% |
| Investors Holding | 93▲ 7.00% |
ESG Score
No data
About Repro-Med Systems, Inc.
101 employeesRepro Med Systems, Inc. dba KORU Medical System develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion S...